Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 May 12;13:891270. doi: 10.3389/fgene.2022.891270

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2022 Zhong, Qin, Yu, Xia, Gu, Qian, Hu, Su and Zhang.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Nomogram for patients with CRC. (A) Nomogram for predicting 3- and 5-year survival for CRC patients based on tumor-infiltrating immune cells. (B) Kaplan–Meier estimates of patients’ survival status and time using the median risk score cut-off, which divided patients into low-risk and high-risk groups based on the training cohort. (C) ROC analysis of the sensitivity and specificity of the survival time by the tumor-infiltrating immune cells based on the risk score for the training cohort. (D) Calibration curve for the prediction of 3-year overall survival based on the training cohort. (E) Calibration curve for the prediction of 5-year overall survival based on the training cohort.